✦ LIBER ✦
Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States
✍ Scribed by Thomas E. Delea; May Hagiwara; Simu K. Thomas; Jean-Francois Baladi; Pradyumna D. Phatak; Thomas D. Coates
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 132 KB
- Volume
- 83
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.